Cargando…
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Although several genetic associations with scleroderma (SSc) are defined, very little is known on genetic susceptibility to SSc-associated interstitial lung disease (SSc-ILD). A number of common polymorphisms have been associated with SSc-ILD, but most have not been replicated in separate population...
Autores principales: | Stock, Carmel J. W., De Lauretis, Angelo, Visca, Dina, Daccord, Cecile, Kokosi, Maria, Kouranos, Vasilis, Margaritopoulos, George, George, Peter M., Molyneaux, Philip L., Nihtyanova, Svetlana, Chua, Felix, Maher, Toby M., Ong, Voon, Abraham, David J., Denton, Christopher P., Wells, Athol U., Wain, Louise V., Renzoni, Elisabetta A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142048/ https://www.ncbi.nlm.nih.gov/pubmed/31916109 http://dx.doi.org/10.1007/s10067-019-04922-6 |
Ejemplares similares
-
Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017) -
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
por: Lindahl, Gisela E, et al.
Publicado: (2013) -
Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease
por: Silver, R. M., et al.
Publicado: (2019) -
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010) -
Scleroderma and interstitial lung disease - A case report
por: Gul, Fahad, et al.
Publicado: (2022)